Welcome to LookChem.com Sign In|Join Free
  • or
α-(4’-Hydroxyphenyl)phloroacetophenone is an organic compound that serves as an intermediate in the synthesis of Genistein, a naturally occurring isoflavone with various biological activities. It is characterized by its tan solid appearance and is utilized in the pharmaceutical and chemical industries for the production of Genistein and related compounds.

15485-65-1

Post Buying Request

15485-65-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

15485-65-1 Usage

Uses

Used in Pharmaceutical Industry:
α-(4’-Hydroxyphenyl)phloroacetophenone is used as a chemical intermediate for the synthesis of Genistein, which is known for its potential health benefits and applications in the development of pharmaceutical products. Genistein has been studied for its effects on cancer, bone health, and cardiovascular diseases, among other areas.
Used in Chemical Industry:
In the chemical industry, α-(4’-Hydroxyphenyl)phloroacetophenone is used as a starting material for the production of various compounds, including Genistein and its derivatives. These compounds can be further utilized in the development of new pharmaceuticals, nutraceuticals, and other related products.
Used in Research and Development:
α-(4’-Hydroxyphenyl)phloroacetophenone is also used in research and development settings to study the properties and potential applications of Genistein and its related compounds. This includes investigating their biological activities, mechanisms of action, and potential therapeutic uses in various diseases and conditions.

Preparation

Preparation by reaction of p-hydroxyphenyl-acetonitrile with phloroglucinol (Hoesch reaction) (58%).

Check Digit Verification of cas no

The CAS Registry Mumber 15485-65-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,5,4,8 and 5 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 15485-65:
(7*1)+(6*5)+(5*4)+(4*8)+(3*5)+(2*6)+(1*5)=121
121 % 10 = 1
So 15485-65-1 is a valid CAS Registry Number.
InChI:InChI=1/C14H12O5/c15-9-3-1-8(2-4-9)5-11(17)14-12(18)6-10(16)7-13(14)19/h1-4,6-7,15-16,18-19H,5H2

15485-65-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-(4-Hydroxyphenyl)-1-(2,4,6-trihydroxyphenyl)ethanone

1.2 Other means of identification

Product number -
Other names 4-hydroxybenzyl 2,4,6-trihydroxyphenyl ketone

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:15485-65-1 SDS

15485-65-1Synthetic route

3,5-dihydroxyphenol
108-73-6

3,5-dihydroxyphenol

4-hydroxyphenylacetate
156-38-7

4-hydroxyphenylacetate

2,4,4',6-tetrahydroxydeoxybenzoin
15485-65-1

2,4,4',6-tetrahydroxydeoxybenzoin

Conditions
ConditionsYield
With boron trifluoride diethyl etherate at 0℃; for 5h;83%
With boron trifluoride diethyl etherate In various solvent(s) at 90℃; for 0.0666667h; Friedel-Crafts reaction; microwave irradiation;67%
With boron trifluoride diethyl etherate at 85℃; for 1.5h; Condensation;
Stage #1: 3,5-dihydroxyphenol; 4-hydroxyphenylacetate With boron trifluoride diethyl etherate at 70 - 80℃; Heating / reflux;
Stage #2: In DMF (N,N-dimethyl-formamide)
With boron trifluoride diethyl etherate at 85℃; for 1.5h;
3,5-dihydroxyphenol
108-73-6

3,5-dihydroxyphenol

4-cyanomethylphenol
14191-95-8

4-cyanomethylphenol

2,4,4',6-tetrahydroxydeoxybenzoin
15485-65-1

2,4,4',6-tetrahydroxydeoxybenzoin

Conditions
ConditionsYield
Stage #1: 3,5-dihydroxyphenol; 4-cyanomethylphenol With hydrogenchloride In acetic acid methyl ester at 5 - 20℃; for 19h; Hoesch reaction;
Stage #2: With sodium hydroxide; ethanol; water In ethyl acetate at 75 - 101℃; for 7h; pH=4.0; Product distribution / selectivity; Heating / reflux;
78.6%
With hydrogenchloride In diethyl ether at 0℃; for 24h;72%
With bis(trifluoromethanesulfonyl)amide In various solvent(s) at 90℃; for 0.0666667h; Hoesch reaction; microwave irradiation;65%
5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

2,4,4',6-tetrahydroxydeoxybenzoin
15485-65-1

2,4,4',6-tetrahydroxydeoxybenzoin

Conditions
ConditionsYield
With sodium hydroxide at 60℃;65%
4,6-Dihydroxy-2-(4-hydroxy-phenyl)-benzofuran-3-one
19858-38-9

4,6-Dihydroxy-2-(4-hydroxy-phenyl)-benzofuran-3-one

2,4,4',6-tetrahydroxydeoxybenzoin
15485-65-1

2,4,4',6-tetrahydroxydeoxybenzoin

Conditions
ConditionsYield
With hydrogen; palladium on activated charcoal In ethanol
C14H13NO4*ClH
1260505-68-7

C14H13NO4*ClH

2,4,4',6-tetrahydroxydeoxybenzoin
15485-65-1

2,4,4',6-tetrahydroxydeoxybenzoin

Conditions
ConditionsYield
With hydrogenchloride; water Reflux;
With hydrogenchloride; water In methanol for 12h; Reflux; Industrial scale;59.1 kg
4-hydroxy-benzaldehyde
123-08-0

4-hydroxy-benzaldehyde

2,4,4',6-tetrahydroxydeoxybenzoin
15485-65-1

2,4,4',6-tetrahydroxydeoxybenzoin

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: hydrogen
2: tetrabutylammomium bromide
3: zinc(II) chloride; hydrogenchloride / 1,2-dimethoxyethane / 10 - 20 °C / Industrial scale
4: water; hydrogenchloride / methanol / 12 h / Reflux; Industrial scale
View Scheme
3,5-dihydroxyphenol
108-73-6

3,5-dihydroxyphenol

2,4,4',6-tetrahydroxydeoxybenzoin
15485-65-1

2,4,4',6-tetrahydroxydeoxybenzoin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: zinc(II) chloride; hydrogenchloride / 1,2-dimethoxyethane / 10 - 20 °C / Industrial scale
2: water; hydrogenchloride / methanol / 12 h / Reflux; Industrial scale
View Scheme
4-cyanomethylphenol
14191-95-8

4-cyanomethylphenol

2,4,4',6-tetrahydroxydeoxybenzoin
15485-65-1

2,4,4',6-tetrahydroxydeoxybenzoin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: zinc(II) chloride; hydrogenchloride / 1,2-dimethoxyethane / 10 - 20 °C / Industrial scale
2: water; hydrogenchloride / methanol / 12 h / Reflux; Industrial scale
View Scheme
(4-hydroxyphenyl)methanol
623-05-2

(4-hydroxyphenyl)methanol

2,4,4',6-tetrahydroxydeoxybenzoin
15485-65-1

2,4,4',6-tetrahydroxydeoxybenzoin

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: tetrabutylammomium bromide
2: zinc(II) chloride; hydrogenchloride / 1,2-dimethoxyethane / 10 - 20 °C / Industrial scale
3: water; hydrogenchloride / methanol / 12 h / Reflux; Industrial scale
View Scheme
2,4,4',6-tetrahydroxydeoxybenzoin
15485-65-1

2,4,4',6-tetrahydroxydeoxybenzoin

sodium formate
141-53-7

sodium formate

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

Conditions
ConditionsYield
Stage #1: 2,4,4',6-tetrahydroxydeoxybenzoin; sodium formate With propionyl chloride In acetone at 21 - 32℃; for 1h;
Stage #2: With triethylamine In acetone at 20 - 32℃; for 2.5h;
Stage #3: With sulfuric acid; water In acetone at 20℃; for 16h; Product distribution / selectivity;
94.8%
Stage #1: 2,4,4',6-tetrahydroxydeoxybenzoin; sodium formate With acetyl chloride In acetone at 12 - 25℃; for 2h;
Stage #2: With triethylamine In acetone at 18 - 32℃; for 3h;
Stage #3: With sulfuric acid; water In acetone at 20℃; for 16h; Product distribution / selectivity;
91.7%
Stage #1: 2,4,4',6-tetrahydroxydeoxybenzoin; sodium formate With isobutyryl chloride In acetone at 21 - 32℃; for 2h;
Stage #2: With triethylamine In acetone at 18 - 32℃; for 2.5h;
Stage #3: With sulfuric acid; water In acetone at 20℃; for 16h; Product distribution / selectivity;
90.2%
2,4,4',6-tetrahydroxydeoxybenzoin
15485-65-1

2,4,4',6-tetrahydroxydeoxybenzoin

sodium formate
141-53-7

sodium formate

propionyl chloride
79-03-8

propionyl chloride

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

Conditions
ConditionsYield
Stage #1: sodium formate; propionyl chloride In acetone at 21 - 35℃; for 3h;
Stage #2: 2,4,4',6-tetrahydroxydeoxybenzoin With triethylamine In acetone at 20 - 22℃; for 2h;
Stage #3: With sulfuric acid; water In acetone at 20℃; for 16h;
93%
Stage #1: 2,4,4',6-tetrahydroxydeoxybenzoin; sodium formate; propionyl chloride In acetone at 21 - 35℃; for 2h;
Stage #2: With triethylamine In acetone at 18 - 35℃; for 3h;
Stage #3: With sulfuric acid; water In acetone at 60 - 70℃; for 1.5h;
92.2%
Stage #1: 2,4,4',6-tetrahydroxydeoxybenzoin; sodium formate; propionyl chloride In formic acid ethyl ester at 23 - 35℃; for 3h;
Stage #2: With triethylamine In formic acid ethyl ester at 18 - 22℃; for 16h;
Stage #3: With sulfuric acid; water In formic acid ethyl ester at 80℃;
92.7%
2,4,4',6-tetrahydroxydeoxybenzoin
15485-65-1

2,4,4',6-tetrahydroxydeoxybenzoin

sodium formate
141-53-7

sodium formate

isobutyryl chloride
79-30-1

isobutyryl chloride

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

Conditions
ConditionsYield
Stage #1: 2,4,4',6-tetrahydroxydeoxybenzoin; sodium formate; isobutyryl chloride In acetone at 21 - 32℃; for 3h;
Stage #2: With triethylamine In acetone at 18 - 32℃; for 2h;
Stage #3: With sulfuric acid; water In acetone at 60 - 70℃; for 3h;
90.3%
2,4,4',6-tetrahydroxydeoxybenzoin
15485-65-1

2,4,4',6-tetrahydroxydeoxybenzoin

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

Conditions
ConditionsYield
With boron trifluoride diethyl etherate; methanesulfonyl chloride In N,N-dimethyl-formamide at 50℃; for 12h; Molecular sieve;90%
With methanesulfonyl chloride In N,N-dimethyl-formamide at 60 - 70℃; for 1h;53%
Multi-step reaction with 2 steps
1: pyridine / Behandeln des Reaktionsprodukts mit wss. Natronlauge
2: 325 °C
View Scheme
2,4,4',6-tetrahydroxydeoxybenzoin
15485-65-1

2,4,4',6-tetrahydroxydeoxybenzoin

N,N-dimethyl-formamide
68-12-2, 33513-42-7

N,N-dimethyl-formamide

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

Conditions
ConditionsYield
Stage #1: N,N-dimethyl-formamide With phosphorus pentachloride at 55℃; for 0.333333h; Chlorination;
Stage #2: 2,4,4',6-tetrahydroxydeoxybenzoin With boron trifluoride diethyl etherate In N,N-dimethyl-formamide at 20℃; for 1h; Cycloaddition;
90%
Stage #1: 2,4,4',6-tetrahydroxydeoxybenzoin With boron trifluoride diethyl etherate In N,N-dimethyl-formamide at 50 - 60℃; Cooling with ice;
Stage #2: N,N-dimethyl-formamide With methanesulfonyl chloride at 50 - 70℃;
84%
With boron trifluoride diethyl etherate; methanesulfonyl chloride 1.) irradiation, reflux, 15 s, 2.) irradiation, reflux, 1 min; Yield given. Multistep reaction;
With phosphorus pentachloride; boron trifluoride diethyl etherate at 20℃; for 1h; Cyclization;
With boron trifluoride diethyl etherate; methanesulfonyl chloride at 50 - 100℃;
glutaric anhydride,
108-55-4

glutaric anhydride,

2,4,4',6-tetrahydroxydeoxybenzoin
15485-65-1

2,4,4',6-tetrahydroxydeoxybenzoin

4-[5,7-dihydroxy-3-(4-hydroxyphenyl)-4-oxo-4H-chromen-2-yl]butanoic acid
272463-80-6

4-[5,7-dihydroxy-3-(4-hydroxyphenyl)-4-oxo-4H-chromen-2-yl]butanoic acid

Conditions
ConditionsYield
Stage #1: glutaric anhydride,; 2,4,4',6-tetrahydroxydeoxybenzoin With triethylamine In 1,4-dioxane at 100℃; for 0.5h;
Stage #2: With 1,8-diazabicyclo[5.4.0]undec-7-ene In 1,4-dioxane at 100℃;
Stage #3: With sulfuric acid In 1,4-dioxane; water at 80℃;
88%
formic acid
64-18-6

formic acid

2,4,4',6-tetrahydroxydeoxybenzoin
15485-65-1

2,4,4',6-tetrahydroxydeoxybenzoin

propionic acid anhydride
123-62-6

propionic acid anhydride

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

Conditions
ConditionsYield
Stage #1: formic acid; propionic acid anhydride at 25 - 45℃; for 2h;
Stage #2: 2,4,4',6-tetrahydroxydeoxybenzoin With triethylamine In acetone at 20 - 40℃; for 19h;
Stage #3: With sulfuric acid; water In acetone at 60℃;
86.5%
Stage #1: formic acid; 2,4,4',6-tetrahydroxydeoxybenzoin; propionic acid anhydride at 25 - 45℃; for 2h;
Stage #2: With triethylamine at 20 - 40℃; for 19h;
Stage #3: With sulfuric acid; water at 75℃; for 2.5h;
82.5%
2,4,4',6-tetrahydroxydeoxybenzoin
15485-65-1

2,4,4',6-tetrahydroxydeoxybenzoin

Propionic formic anhydride
10500-31-9

Propionic formic anhydride

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

Conditions
ConditionsYield
Stage #1: 2,4,4',6-tetrahydroxydeoxybenzoin; Propionic formic anhydride With triethylamine In acetone at 25 - 40℃; for 3h;
Stage #2: With sulfuric acid; water In acetone at 20 - 60℃;
84%
formic acid
64-18-6

formic acid

2,4,4',6-tetrahydroxydeoxybenzoin
15485-65-1

2,4,4',6-tetrahydroxydeoxybenzoin

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

Conditions
ConditionsYield
Stage #1: formic acid; 2,4,4',6-tetrahydroxydeoxybenzoin With acetic anhydride; triethylamine at 20℃; for 24h; Industrial scale;
Stage #2: With hydrogenchloride; water In methanol at 20℃; for 22h; Industrial scale;
79.5%
1,3,5-Triazine
290-87-9

1,3,5-Triazine

2,4,4',6-tetrahydroxydeoxybenzoin
15485-65-1

2,4,4',6-tetrahydroxydeoxybenzoin

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

Conditions
ConditionsYield
With boron trifluoride diethyl etherate; acetic anhydride In diethyl ether; acetic acid Heating;78%
2,4,4',6-tetrahydroxydeoxybenzoin
15485-65-1

2,4,4',6-tetrahydroxydeoxybenzoin

methyl 10-chloro-10-oxodecanoate
14065-32-8

methyl 10-chloro-10-oxodecanoate

5,7,4'-Trihydroxy-2-[8-(methoxycarbonyl)octyl]isoflavone

5,7,4'-Trihydroxy-2-[8-(methoxycarbonyl)octyl]isoflavone

Conditions
ConditionsYield
With tetrabutylammomium bromide; potassium carbonate In acetone for 46h; Cyclization; Heating;60%
2,4,4',6-tetrahydroxydeoxybenzoin
15485-65-1

2,4,4',6-tetrahydroxydeoxybenzoin

methyl 8-chloro-8-oxooctanoate
41624-92-4

methyl 8-chloro-8-oxooctanoate

5,7,4'-Trihydroxy-2-[6-(methoxycarbonyl)hexyl]isoflavone

5,7,4'-Trihydroxy-2-[6-(methoxycarbonyl)hexyl]isoflavone

Conditions
ConditionsYield
With tetrabutylammomium bromide; potassium carbonate In acetone for 46h; Cyclization; Heating;56%
2,4,4',6-tetrahydroxydeoxybenzoin
15485-65-1

2,4,4',6-tetrahydroxydeoxybenzoin

sodium formate
141-53-7

sodium formate

benzoyl chloride
98-88-4

benzoyl chloride

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on
446-72-0

5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on

Conditions
ConditionsYield
Stage #1: sodium formate; benzoyl chloride In acetone at 21 - 40℃; for 3h;
Stage #2: 2,4,4',6-tetrahydroxydeoxybenzoin With triethylamine In acetone at 21 - 35℃; for 3h;
Stage #3: With sulfuric acid; water In acetone at 20℃; for 16h;
52.7%
ethyl glutaroyl chloride
5205-39-0

ethyl glutaroyl chloride

2,4,4',6-tetrahydroxydeoxybenzoin
15485-65-1

2,4,4',6-tetrahydroxydeoxybenzoin

2-[3-(Ethoxycarbonyl)propyl]-5,7,4'-trihydroxyisoflavone

2-[3-(Ethoxycarbonyl)propyl]-5,7,4'-trihydroxyisoflavone

Conditions
ConditionsYield
With tetrabutylammomium bromide; potassium carbonate In acetone for 34h; Cyclization; Heating;50%
2,4,4',6-tetrahydroxydeoxybenzoin
15485-65-1

2,4,4',6-tetrahydroxydeoxybenzoin

allyl bromide
106-95-6

allyl bromide

C26H28O5

C26H28O5

Conditions
ConditionsYield
Stage #1: 2,4,4',6-tetrahydroxydeoxybenzoin With potassium carbonate In acetone at 60 - 75℃; for 1h;
Stage #2: allyl bromide In acetone for 24h; Inert atmosphere; Reflux;
50%
2,4,4',6-tetrahydroxydeoxybenzoin
15485-65-1

2,4,4',6-tetrahydroxydeoxybenzoin

methyl adipoyl chloride
35444-44-1

methyl adipoyl chloride

5,7,4'-Trihydroxy-2-[4-(methoxycarbonyl)butyl]isoflavone
218899-45-7

5,7,4'-Trihydroxy-2-[4-(methoxycarbonyl)butyl]isoflavone

Conditions
ConditionsYield
With tetrabutylammomium bromide; potassium carbonate In acetone for 34h; Cyclization; Heating;49%
1,4-dioxane-2,6-dione
4480-83-5

1,4-dioxane-2,6-dione

2,4,4',6-tetrahydroxydeoxybenzoin
15485-65-1

2,4,4',6-tetrahydroxydeoxybenzoin

{[5,7-dihydroxy-3-(4-hydroxyphenyl)-4-oxo-4H-chromen-2-yl]methoxy}acetic acid

{[5,7-dihydroxy-3-(4-hydroxyphenyl)-4-oxo-4H-chromen-2-yl]methoxy}acetic acid

Conditions
ConditionsYield
Stage #1: 1,4-dioxane-2,6-dione; 2,4,4',6-tetrahydroxydeoxybenzoin With triethylamine In 1,4-dioxane at 100℃; for 0.5h;
Stage #2: With 1,8-diazabicyclo[5.4.0]undec-7-ene In 1,4-dioxane at 100℃;
Stage #3: With sulfuric acid In 1,4-dioxane; water at 80℃;
44%
succinic acid anhydride
108-30-5

succinic acid anhydride

2,4,4',6-tetrahydroxydeoxybenzoin
15485-65-1

2,4,4',6-tetrahydroxydeoxybenzoin

3-[5,7-dihydroxy-3-(4-hydroxyphenyl)-4-oxo-4H-chromen-2-yl]propanoic acid
263698-79-9

3-[5,7-dihydroxy-3-(4-hydroxyphenyl)-4-oxo-4H-chromen-2-yl]propanoic acid

Conditions
ConditionsYield
Stage #1: succinic acid anhydride; 2,4,4',6-tetrahydroxydeoxybenzoin With triethylamine In 1,4-dioxane at 100℃; for 0.5h;
Stage #2: With 1,8-diazabicyclo[5.4.0]undec-7-ene In 1,4-dioxane at 100℃;
Stage #3: With sulfuric acid In 1,4-dioxane; water at 80℃;
24%
cis-1,2-cyclopropanedicarboxylic acid anhydride
5617-74-3

cis-1,2-cyclopropanedicarboxylic acid anhydride

2,4,4',6-tetrahydroxydeoxybenzoin
15485-65-1

2,4,4',6-tetrahydroxydeoxybenzoin

2-[5,7-dihydroxy-3-(4-hydroxyphenyl)-4-oxo-4H-chromen-2-yl]cyclopropanecarboxylic acid

2-[5,7-dihydroxy-3-(4-hydroxyphenyl)-4-oxo-4H-chromen-2-yl]cyclopropanecarboxylic acid

Conditions
ConditionsYield
Stage #1: cis-1,2-cyclopropanedicarboxylic acid anhydride; 2,4,4',6-tetrahydroxydeoxybenzoin With triethylamine In 1,4-dioxane at 100℃; for 0.5h;
Stage #2: With 1,8-diazabicyclo[5.4.0]undec-7-ene In 1,4-dioxane at 100℃;
Stage #3: With sulfuric acid In 1,4-dioxane; water at 80℃;
22%
2,4,4',6-tetrahydroxydeoxybenzoin
15485-65-1

2,4,4',6-tetrahydroxydeoxybenzoin

epichlorohydrin
106-89-8

epichlorohydrin

C26H28O9

C26H28O9

Conditions
ConditionsYield
With potassium carbonate; acetone In N,N-dimethyl-formamide at 70℃;20%
2,4,4',6-tetrahydroxydeoxybenzoin
15485-65-1

2,4,4',6-tetrahydroxydeoxybenzoin

epichlorohydrin
106-89-8

epichlorohydrin

C23H24O8

C23H24O8

Conditions
ConditionsYield
Stage #1: 2,4,4',6-tetrahydroxydeoxybenzoin; epichlorohydrin With tetrabutylammomium bromide for 1h; Reflux;
Stage #2: With sodium hydroxide In water at 20℃; for 1.25h;
19.6%
2,4,4',6-tetrahydroxydeoxybenzoin
15485-65-1

2,4,4',6-tetrahydroxydeoxybenzoin

Ethyl oxalyl chloride
4755-77-5

Ethyl oxalyl chloride

5,7-dihydroxy-3-(4-hydroxy-phenyl)-4-oxo-4H-chromene-2-carboxylic acid
22151-32-2

5,7-dihydroxy-3-(4-hydroxy-phenyl)-4-oxo-4H-chromene-2-carboxylic acid

Conditions
ConditionsYield
With pyridine Behandeln des Reaktionsprodukts mit wss. Natronlauge;
2,4,4',6-tetrahydroxydeoxybenzoin
15485-65-1

2,4,4',6-tetrahydroxydeoxybenzoin

Ethyl oxalyl chloride
4755-77-5

Ethyl oxalyl chloride

5,7-dihydroxy-3-(4-hydroxy-phenyl)-4-oxo-4H-chromene-2-carboxylic acid ethyl ester
111790-01-3

5,7-dihydroxy-3-(4-hydroxy-phenyl)-4-oxo-4H-chromene-2-carboxylic acid ethyl ester

Conditions
ConditionsYield
With pyridine
2,4,4',6-tetrahydroxydeoxybenzoin
15485-65-1

2,4,4',6-tetrahydroxydeoxybenzoin

methyl chloroformate
79-22-1

methyl chloroformate

4,5,7-trihydroxy-3-(4-hydroxy-phenyl)-coumarin
100954-25-4

4,5,7-trihydroxy-3-(4-hydroxy-phenyl)-coumarin

Conditions
ConditionsYield
With potassium carbonate; acetone Behandeln des Reaktionsprodukts mit wss. Natronlauge;
2,4,4',6-tetrahydroxydeoxybenzoin
15485-65-1

2,4,4',6-tetrahydroxydeoxybenzoin

dimethyl sulfate
77-78-1

dimethyl sulfate

2'-hydroxy-4',6-dimethoxy-2-(p-methoxyphenyl)acetophenone
39604-68-7

2'-hydroxy-4',6-dimethoxy-2-(p-methoxyphenyl)acetophenone

Conditions
ConditionsYield
With potassium carbonate In acetone Heating;

15485-65-1Relevant academic research and scientific papers

Microwave-promoted synthesis of polyhydroxydeoxybenzoins in ionic liquids

Hakala, Ullastiina,W?h?l?, Kristiina

, p. 8375 - 8378 (2006)

A microwave-promoted synthesis of polyhydroxydeoxybenzoins and -phenylpropanones has been developed, using bis{(trifluoromethyl)sulfonyl}amine (HNTf2) or BF3·OEt2 in an ionic liquid solvent.

Microwave-Mediated Synthesis of Anticarcinogenic Isoflavones from Soybeans

Chang, Yu-Chen,Nair, Muraleedharan G.,Santell, Ross C.,Helferich, William G.

, p. 1869 - 1871 (1994)

Soybean isoflavonoids, 7,4'-dihydroxyisoflavone (daidzein), 7-hydroxy-4'-methoxyisoflavone (formononetin), 5,7,4'-trihydroxyisoflavone (genistein), and 5,7-dihydroxy-4'-methoxyisoflavone (biochanin A), were synthesized in high yields by cyclization of their corresponding ketones in a conventional microwave oven. Keywords: Microwave synthesis; isoflavones; daidzein; genistein; formononetin; biochanin A

Identification of enterodiol as a masker for caffeine bitterness by using a pharmacophore model based on structural analogues of homoeriodictyol

Ley, Jakob P.,Dessoy, Marco,Paetz, Susanne,Blings, Maria,Hoffmann-Lücke, Petra,Reichelt, Katharina V.,Krammer, Gerhard E.,Pienkny, Silke,Brandt, Wolfgang,Wessjohann, Ludger

, p. 6303 - 6311 (2012)

Starting from previous structure-activity relationship studies of taste modifiers based on homoeriodictyol, dihydrochalcones, deoxybenzoins, and trans-3-hydroxyflavones as obvious analogues were investigated for their masking effect against caffeine. The most active compounds of the newly investigated taste modifiers were phloretin, the related dihydrochalcones 3-methoxy-2′,4,4′-trihydroxydihydrochalcone and 2′,4- dihydroxy-3-methoxydihydrochalcone, and the deoxybenzoin 2-(4-hydroxy-3- methoxyphenyl)-1-(4-hydroxyphenyl)ethanone. Starting with the whole set of compounds showing activity >22%, a (Q)SAR pharmacophore model for maskers of caffeine bitterness was calculated to explain the structural requirements. After docking of the pharmacophore into a structural model of the broadly tuned bitter receptor hTAS2R10 and docking of enterolactone and enterodiol as only very weakly related structures, it was possible to predict qualitatively their modulating activity. Enterodiol (25 mg L-1) reduced the bitterness of the 500 mg L-1 caffeine solution by about 30%, whereas enterolactone showed no masking but a slight bitter-enhancing effect.

A Direct Synthesis of 2-(ω-Carboxyalkyl)isoflavones from ortho-Hydroxylated Deoxybenzoins

Mrug, Galyna P.,Demydchuk, Bohdan A.,Bondarenko, Svitlana P.,Sviripa, Vitaliy M.,Wyrebek, Przemyslaw,Mohler, James L.,Fiandalo, Michael V.,Liu, Chunming,Frasinyuk, Mykhaylo S.,Watt, David S.

supporting information, p. 5460 - 5463 (2018/10/20)

As part of a program focused on the development of new antineoplastic agents based on scaffolds found in natural products, we explored the isoflavone family as potential enzyme inhibitors. We required biotin-modified isoflavones to identify potential biological targets, and we selected the C-2 position in isoflavones as an attachment site for an alkyl group bearing a terminal carboxylic acid to which we could attach a biotin derivative. The base-catalyzed condensation of 2,4-dihydroxy-substituted deoxybenzoins with cyclic anhydrides mediated by a combination of triethylamine and 1,8-diazabicyclo[5.4.0]undec-7-ene led to an efficient synthesis of the desired 2-(ω-carboxyalkyl)isoflavones with functional groups at C-5, 6 and 7 and with various substituents in the C-3 phenyl group.

Multifunctional deoxybenzoin-based monomers and resins having reduced flammability

-

Page/Page column 10, (2016/08/10)

The invention provides a novel platform for minimal- or non-flammable polymers, which is based purely on hydrocarbon systems and does not need additives of any kind A key feature is that the hydrocarbons disclosed herein are characterized by degradation mechanisms that produce few flammable volatiles. For example, 2,4,4′,6-tetrahydroxydeoxybenzoin is employed as a multifunctional cross-linker in conjunction with bis-epoxydeoxybenzoin, affording new resins that combine excellent physical and mechanical properties with low flammability.

Technical Process for Preparation of Genistein

Filip, Katarzyna,Kleczkowska-Plichta, Ewa,Ara?ny, Zbigniew,Grynkiewicz, Grzegorz,Polowczyk, Magdalena,Gabarski, Krzysztof,Trzcińska, Kinga

, p. 1354 - 1362 (2016/07/23)

Development and scale-up of the synthetic process for genistein preparation are described. The process was designed with consideration for environmental and economical aspects and optimized in a laboratory scale. In a scale up, on every step quantity of the environmentally unfriendly substrates or solvents was reduced without compromising the quality of the final product, and the waste load was significantly diminished. The optimal duration times of the individual stages were determined, and the number of operations was reduced, leading to lowering of energy consumption. Elaborated process secures good yield and quality expected for pharmaceutical substances.

Multifunctional deoxybenzoin-based epoxies: Synthesis, mechanical properties, and thermal evaluation

Szyndler, Megan W.,Timmons, Justin C.,Yang, Zhan H.,Lesser, Alan J.,Emrick, Todd

, p. 4441 - 4446 (2014/10/15)

We describe 2,4,4′,6-tetrahydroxydeoxybenzoin (THDB) as a multifunctional cross-linker in conjunction with bis-epoxydeoxybenzoin (BEDB), affording new resins that combine excellent physical and mechanical properties with low flammability. The char residue and heat release capacity values of the cross-linked epoxies were measured by thermogravimetric analysis (TGA) and pyrolysis combustion flow calorimetry (PCFC), respectively. Resins fabricated from THDB exhibited low total heat release (13 kJ/g) and high char yields (34%), as well as good mechanical properties, making them suitable candidates for consideration in high performance adhesive applications. The desirable heat release and char yield properties of these structures are realized without the presence of any conventional flame retardant, such as halogenated structures or inorganic fillers that are commonly utilized in commercial materials.

Arylalkyl ketones, benzophenones, desoxybenzoins and chalcones inhibit TNF-α induced expression of ICAM-1: Structure-activity analysis

Kumar, Sarvesh,Reddy L, Chandra Shekhar,Kumar, Yogesh,Kumar, Amit,Singh, Brajendra K.,Kumar, Vineet,Malhotra, Shashwat,Pandey, Mukesh K.,Jain, Rajni,Thimmulappa, Rajesh,Sharma, Sunil K.,Prasad, Ashok K.,Biswal, Shyam,Van Der Eycken, Erik,Depass, Anthony L.,Malhotra, Sanjay V.,Ghosh, Balaram,Parmar, Virinder S.

experimental part, p. 368 - 377 (2012/07/31)

The interaction between leukocytes and the vascular endothelial cells (EC) via cellular adhesion molecules plays an important role in the pathogenesis of various inflammatory and autoimmune diseases. Small molecules that block these interactions have been targeted as potential therapeutic agents against acute and chronic inflammatory diseases. In an effort to identify potent intercellular cell adhesion molecule-1 (ICAM-1) inhibitors, a large number of arylalkyl ketones, benzophenones, desoxybenzoins and chalcones and their analogs (54 in total) have been synthesized and screened for their ICAM-1 inhibitory activity. The structure-activity relationship studies of these compounds identified three potent chalcone derivatives and also demonstrated the possible mechanism for their ICAM-1 inhibitory activities. The most active compound was found to be 79. A large number of arylalkyl ketones, benzophenones, desoxybenzoins and chalcones as well as their analogs (54 in total) were synthesized and screened for their ICAM-1 inhibitory activity. The structure-activity relationship studies of these compounds identified three potent chalcone derivatives and also demonstrated a possible mechanism of their ICAM-1 inhibitory activities. The most active compound was found to be 79. Copyright

Synthesis of Talosin A and B, two bioactive isoflavonoid glycosides

Wu, Zhongtao,Lian, Gaoyana,Yu, Biao,Wang, Zhenzhongc,Zhao, Yiwuc,Xiao, Wei

scheme or table, p. 1725 - 1730 (2011/07/07)

Talosin A and B, namely genistein 7-O-α-L-6-deoxy-talopyranoside and genistein 4',7-di-O-α-L-6-deoxytalopyranoside, which show excellent antifungal and anti-inflammatory activities, were synthesized concisely.

Synthesis and structure-activity relationship study of deoxybenzoins on relaxing effects of porcine coronary artery

Lu, Tzy-Ming,Kuo, Daih-Huang,Ko, Horng-Huey,Ng, Lean-Teik

experimental part, p. 10027 - 10032 (2011/05/17)

Deoxybenzoins are potent antioxidants and tyrosinase inhibitors with potential to be developed as food preservatives and cosmetic ingredients. To explore the potential in cardiovascular protection, 25 polyphenolic deoxybenzoins were synthesized and evaluated for inhibitory effects on KCl-induced porcine coronary arterial contraction. The results revealed deoxybenzoins are significant inhibitors of KCl-induced arterial contraction. Among those synthesized, two-thirds of the deoxybenzoins exhibited moderate to good efficacy on relaxing contracted artery including 2,4-dihydroxydeoxybenzoin with EC50 = 3.30 μM (Emax = 100%, n = 7) and 2,4-dihydroxy-4′-methoxydeoxybenzoin EC50 = 3.70 μM (E max = 100%, n = 5). Deoxybenzoins displayed an endothelium-dependent relaxing manner on the contracted artery; the contractile responses of neither endothelium denuded nor L-NAME deactivated rings were inhibited. The structure-activity relationships of deoxybenzoin on arterial relaxing effects concluded that the 2,4-dihydroxylated deoxybenzoins presented a potential vascular relaxing pharmacophore, with favoring substitution on ring B in the order of H ≤ p-OMe > p-OH > o-OMe > m,p-diOMe ≤ m-OMe.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 15485-65-1